Physician profile
Gary A Dix
NPI 1326046327
$229,828.90
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $58K · 2020: $41K · 2021: $49K · 2022: $56K · 2023: $26K · 2024: $82.34.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $25K · Food and Beverage: $791.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $24,998.33 |
| Food and Beverage | $790.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $182,193.94 | 2019-2023 | Revolve |
| Si-Bone, INC. | $26,474.26 | 2019-2024 | |
| Stryker Corporation | $20,403.26 | 2019-2023 | N/A, Serrato |
| Nuvasive, INC. | $207.73 | 2019 | |
| Boston Scientific Corporation | $136.98 | 2019-2022 | |
| Abbott Laboratories | $113.95 | 2021-2022 | |
| Orthofix Medical, INC. | $85.67 | 2019-2021 | |
| Nevro Corp. | $81.79 | 2021-2022 | |
| Abbvie INC. | $27.77 | 2023 | Botox |
| Providence Medical Technology, INC. | $26.44 | 2019 | |
| Biogen, INC. | $24.60 | 2022 | |
| Centinel Spine, LLC | $20.24 | 2021 | |
| Vertos Medical, INC. | $16.44 | 2022 | |
| Spineology INC. | $15.83 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Dix listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.